Sign In
Buy NTRA
$234.76
+5.96 (+2.60%)
At Close: Jun 23, 2026
Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates
10:35pm, Thursday, 05'th May 2022 Zacks Investment Research
Natera (NTRA) delivered earnings and revenue surprises of 3.33% and 8.77%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates
08:18pm, Thursday, 05'th May 2022
Natera (NTRA) delivered earnings and revenue surprises of 3.33% and 8.77%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Natera Announces First Quarter 2022 Earnings Conference Call
08:03am, Monday, 02'nd May 2022
AUSTIN, Texas , May 2, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its first quarter ended March 31,
Earnings Preview: Natera (NTRA) Q1 Earnings Expected to Decline
07:02pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Natera (NTRA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2 Healthcare Stocks That Could Go Parabolic
03:07pm, Thursday, 28'th Apr 2022 The Motley Fool
These two companies are poised for a comeback.
Analyst Ratings for Natera
03:08pm, Monday, 25'th Apr 2022 Benzinga
Within the last quarter, Natera (NASDAQ:NTRA) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
5
0
0
0
Last 30D
0
1
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022
02:07pm, Monday, 25'th Apr 2022 Benzinga
Upgrades
RBC Capital upgraded the previous rating for United States Steel Corp (NYSE:X) from Sector Perform to Outperform. United States Steel earned $3.64 in the fourth quarter, compared to $0.27 in
These 20 highly rated stocks are expected to rise at least 70% over the next year
10:42am, Wednesday, 20'th Apr 2022 MarketWatch
Favored companies include Uber, General Motors and Twilio.
Signatera ctDNA dynamics are both predictive and prognostic in neoadjuvant TNBC. Lead time up to 30 months between Signatera positivity and radiographic recurrence.
Insiders Buy Over $15M Of 3 Stocks
11:16am, Monday, 21'st Mar 2022 Benzinga
Although US stock futures traded lower this morning on Monday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company's prospects or that
Should You Buy Natera Stock Despite the Scathing Short-Seller Report From Hindenburg?
11:50am, Friday, 18'th Mar 2022 The Motley Fool
The report claims the company's billing practices are deceptive.
Should You Buy Natera Stock Despite the Scathing Short-Seller Report From Hindenburg?
07:50am, Friday, 18'th Mar 2022
The report claims the company's billing practices are deceptive.
Natera jumps 9% as lead independent director makes $5M investment
03:31pm, Wednesday, 16'th Mar 2022 Seeking Alpha
Natera''s <> lead independent director of board of directors and partner at Sequoia Capital, Roelof Botha has invested $5M to purchase shares of the company on the open…
CareDx wins $45 mln verdict against Natera for false advertising
06:37pm, Tuesday, 15'th Mar 2022 Reuters
Genetic testing company Natera Inc owes rival CareDx Inc $44.9 million for making false claims about the effectiveness of Natera''s Prospera test for assessing the risk that a person''s body will reject a kidney transplant, a Delaware jury said.
Tuesday’s Top Analyst Upgrades and Downgrades: Accenture, Bumble, Chevron, Hormel, Lululemon, Nike, Target, Trip.com, Tyson Foods, Unilever, Zoom Video and More
12:54pm, Tuesday, 15'th Mar 2022 24/7 Wall street
Tuesday''s top analyst upgrades and downgrades included Accenture, Bumble, Chevron, Fortive, Hormel Foods, Interpublic Group, Lululemon Athletica, Natera, Nike, NOV, Target, Trip.com, Tyson Foods, Unilever and Zoom Video Communications.
